Clinical Trials
31 trialsIndocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
St. Jude Children's Research Hospital
Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors
Grit Biotechnology
Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors
TCRCure Biopharma Ltd.
This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors
Innovent Biologics Technology Limited (Shanghai R&D Center)
Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors
TCRCure Biopharma Ltd.
An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours
Suzhou BlueHorse Therapeutics Co., Ltd.
Genetically Modified T Cells Treating Malignant Tumors
The First Affiliated Hospital of Zhengzhou University
HS-IT201 Injection in the Treatment of Advanced Solid Tumors
Qingdao Sino-Cell Biomedicine Co., Ltd.
Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
An Exploratory Study by Fast CAR T Cells
Shanghai Cell Therapy Group Co.,Ltd
Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors
University of Texas Southwestern Medical Center
Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors
University of Michigan Rogel Cancer Center
Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors
Shanghai Cell Therapy Group Co.,Ltd
An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells
Shanghai Cell Therapy Group Co.,Ltd
[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors
SmartNuclide Biopharma
A Clinical Study on TILs for the Treatment of Advanced Solid Tumors
Suzhou BlueHorse Therapeutics Co., Ltd.
A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors
Suzhou BlueHorse Therapeutics Co., Ltd.
A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors
Suzhou BlueHorse Therapeutics Co., Ltd.
A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors
SmartNuclide Biopharma
KSH01-R02-101 Solid Tumors
TCRx Therapeutics Co.Ltd
Exploratory Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Gynecologic Tumors
RenJi Hospital
TIL Cells for the Treatment of the Advanced Solid Tumors Patients
Fujian Cancer Hospital
A Study of RD14-01 in Patients With Advanced Solid Tumors
Peking University
αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
Shanghai Mengchao Cancer Hospital
RD07 Cell Injection in the Treatment of Patients With Advanced Claudin18.2 Positive Solid Tumors
Peking University
An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
The First Affiliated Hospital with Nanjing Medical University
Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid Tumors
Sinotau Pharmaceutical Group
A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor
Seoul National University Hospital
A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors
Allife Medical Science and Technology Co., Ltd.
DC-CIK
Allife Medical Science and Technology Co., Ltd.
Metronomic
Miller Children's & Women's Hospital Long Beach